Back to User profile » Dr Yanling Cheng

Paper published by Dr Yanling Cheng:


LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y

Journal of Hepatocellular Carcinoma 2022, 9:203-220

Published Date: 22 March 2022